Hepatocyte-Specific Fads1 Overexpression Attenuates Western Diet-Induced Metabolic Phenotypes in a Rat Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094836 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dushan T Ghooray und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY 40202, US…. Hauptthemen laut MEDLINE: Delta-5 Fatty Acid Desaturase, Diet, Western, Fatty Acid Desaturases, Hepatocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAAA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Fatty acid desaturase 1 (FADS1) is a rate-limiting enzyme in long-chain polyunsaturated fatty acid (LCPUFA) synthesis. Reduced activity of FADS1 was observed in metabolic dysfunction-associated steatotic liver disease (MASLD). The aim of this study was to determine whether adeno-associated virus serotype 8 (AAV8) mediated hepatocyte-specific overexpression of Fads1 (AAV8-Fads1) attenuates western diet-induced metabolic phenotypes in a rat model. Male weanling Sprague-Dawley rats were fed with a chow diet, or low-fat high-fructose (LFHFr) or high-fat high-fructose diet (HFHFr) ad libitum for 8 weeks. Metabolic phenotypes were evaluated at the endpoint. AAV8-Fads1 injection restored hepatic FADS1 protein levels in both LFHFr and HFHFr-fed rats. While AAV8-Fads1 injection led to improved glucose tolerance and insulin signaling in LFHFr-fed rats, it significantly reduced plasma triglyceride (by ~50%) and hepatic cholesterol levels (by ~25%) in HFHFr-fed rats. Hepatic lipidomics analysis showed that FADS1 activity was rescued by AAV8-FADS1 in HFHFr-fed rats, as shown by the restored arachidonic acid (AA)/dihomo-γ-linolenic acid (DGLA) ratio, and that was associated with reduced monounsaturated fatty acid (MUFA). Our data suggest that the beneficial role of AAV8-Fads1 is likely mediated by the inhibition of fatty acid re-esterification. FADS1 is a promising therapeutic target for MASLD in a diet-dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY 40202, USA.
- Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
- Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Hepatobiology & Toxicology Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
- Alcohol Research Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
- Robley Rex Veterans Affairs Medical Center, Louisville, KY 40206, USA.
ORCID-Profile: Craig J McClain, Ming Song
Förderung
- NIH HHS
- NIAAA NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- BLRD VA
- National Institutes of Health
- the Veterans Administration
- the Jewish Heritage Fund
Zitieren
APA
Ghooray, D. T., Xu, M., Shi, H., McClain, C. J., & Song, M. (2024). Hepatocyte-Specific Fads1 Overexpression Attenuates Western Diet-Induced Metabolic Phenotypes in a Rat Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094836
Vancouver
Ghooray DT, Xu M, Shi H, McClain CJ, Song M. Hepatocyte-Specific Fads1 Overexpression Attenuates Western Diet-Induced Metabolic Phenotypes in a Rat Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094836
BibTeX
@article{Ghooray2024,
author = {Ghooray, Dushan T and Xu, Manman and Shi, Hongxue and McClain, Craig J and Song, Ming},
title = {Hepatocyte-Specific Fads1 Overexpression Attenuates Western Diet-Induced Metabolic Phenotypes in a Rat Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094836}
}
EUVIMED